145 related articles for article (PubMed ID: 36455864)
1. Age-adjusted Charlson Comorbidity Index is a valuable prognostic tool in operable soft tissue sarcoma of trunk and extremities.
Telli TA; Alan O; Demircan NC; Sariyar N; Arikan R; Basoglu T; Yasar A; Celebi A; Isik S; Sofulu O; Erol B; Turkoz HK; Ozgen Z; Ercelep O; Dane F; Yumuk PF
Orthop Traumatol Surg Res; 2023 May; 109(3):103491. PubMed ID: 36455864
[TBL] [Abstract][Full Text] [Related]
2. Elevated Controlling Nutritional Status (CONUT) Score is Associated with Poor Long-term Survival in Patients with Low-grade Soft-tissue Sarcomas Treated with Surgical Resection.
Liang Y; Hou T; Que Y; Zhao B; Xiao W; Zhang X; Zhou Z
Clin Orthop Relat Res; 2019 Oct; 477(10):2287-2295. PubMed ID: 31107315
[TBL] [Abstract][Full Text] [Related]
3. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapy.
Aoyama T; Yamamoto N; Kamiya M; Murakawa M; Tamagawa H; Sawazaki S; Numata M; Kobayashi S; Ueno M; Morimoto M; Shiozawa M; Yukawa N; Oshima T; Yoshikawa T; Rino Y; Masuda M; Morinaga S
J Cancer Res Ther; 2020 Dec; 16(Supplement):S116-S121. PubMed ID: 33380664
[TBL] [Abstract][Full Text] [Related]
4. [Soft tissue sarcoma of the upper extremities. Analysis of factors relevant for prognosis in 160 patients].
Lehnhardt M; Hirche C; Daigeler A; Goertz O; Ring A; Hirsch T; Drücke D; Hauser J; Steinau HU
Chirurg; 2012 Feb; 83(2):143-52. PubMed ID: 21695557
[TBL] [Abstract][Full Text] [Related]
5. The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.
Di Donato V; Page Z; Bracchi C; Tomao F; Musella A; Perniola G; Panici PB
J Gynecol Oncol; 2019 Jan; 30(1):e6. PubMed ID: 30479090
[TBL] [Abstract][Full Text] [Related]
6. The profile of extremity and trunk soft tissue sarcoma in a tertiary referral center.
Mahmoud AMA; Mahmoud M; Charaf A; Moneer MM
J Egypt Natl Canc Inst; 2017 Jun; 29(2):89-94. PubMed ID: 28462849
[TBL] [Abstract][Full Text] [Related]
7. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer.
Wang Z; Zhong Y; Zhou Y; Mao F; Zhang X; Wang C; Sun Q
Clin Interv Aging; 2023; 18():1163-1174. PubMed ID: 37525754
[TBL] [Abstract][Full Text] [Related]
9. Comparison of outcome and toxicity of postoperative intensity-modulated radiation therapy with two-dimensional radiotherapy in patients with soft tissue sarcoma of extremities and trunk.
Wang J; Song Y; Liu X; Jin J; Wang W; Yu Z; Liu Y; Li N; Fang H; Ren H; Tang Y; Tang Y; Chen B; Lu N; Qi S; Wang S; Li Y
Cancer Med; 2019 Mar; 8(3):902-909. PubMed ID: 30740916
[TBL] [Abstract][Full Text] [Related]
10. The influence of anatomic location on outcomes in patients with localized primary soft tissue sarcoma.
Zhao R; Yu X; Feng Y; Wang J; Mao Y; Yin W; Zhang Z; Guo X; Ma S
Jpn J Clin Oncol; 2018 Sep; 48(9):799-805. PubMed ID: 30060202
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of the age-adjusted Charlson comorbidity index in patients over 60 years old with laryngeal squamous cell carcinoma].
Li ZL; An CM; Gao ZH; Cao JZ; Huangfu H; Nan J; Zhu BY; Zhang Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Aug; 56(8):837-843. PubMed ID: 34521168
[No Abstract] [Full Text] [Related]
12. Prognostic Value of the Age-Adjusted Charlson Comorbidity Index (ACCI) on Short- and Long-Term Outcome in Patients with Advanced Primary Epithelial Ovarian Cancer.
Kahl A; du Bois A; Harter P; Prader S; Schneider S; Heitz F; Traut A; Alesina PF; Meier B; Walz M; Brueckner A; Groeben HT; Brunkhorst V; Heikaus S; Ataseven B
Ann Surg Oncol; 2017 Nov; 24(12):3692-3699. PubMed ID: 28871563
[TBL] [Abstract][Full Text] [Related]
13. Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma: Results of a retrospective multicenter study.
Bonvalot S; Wunder J; Gronchi A; Broto JM; Turcotte R; Rastrelli M; Papai Z; Radaelli S; Lindner LH; Shumelinsky F; Cubillo A; Rutkowski P; Demaire C; Strens D; Nalbantov G
Eur J Surg Oncol; 2021 Aug; 47(8):2166-2172. PubMed ID: 33676792
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of age-adjusted Charlson comorbidity index in laparoscopic resection for hilar cholangiocarcinoma.
Cai C; Tao L; Li D; Wang L; Xiao E; Luo G; Yan Z; Wang Y; Li D
Scand J Gastroenterol; 2024 Mar; 59(3):333-343. PubMed ID: 38018772
[TBL] [Abstract][Full Text] [Related]
15. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy.
Takahara N; Nakai Y; Saito K; Sasaki T; Suzuki Y; Inokuma A; Oyama H; Kanai S; Suzuki T; Sato T; Hakuta R; Ishigaki K; Saito T; Hamada T; Mizuno S; Kogure H; Tada M; Isayama H; Koike K
J Gastroenterol Hepatol; 2020 Oct; 35(10):1828-1835. PubMed ID: 32267557
[TBL] [Abstract][Full Text] [Related]
16. Comorbidity, body mass index, and performance status as prognostic factors in older patients with soft-tissue sarcoma.
Tamiya H; Imura Y; Wakamatsu T; Takenaka S
J Geriatr Oncol; 2022 Jun; 13(5):673-681. PubMed ID: 35219635
[TBL] [Abstract][Full Text] [Related]
17. The Age-Adjusted Charlson Comorbidity Index Predicts Prognosis in Elderly Cancer Patients.
Zhou S; Zhang XH; Zhang Y; Gong G; Yang X; Wan WH
Cancer Manag Res; 2022; 14():1683-1691. PubMed ID: 35573259
[TBL] [Abstract][Full Text] [Related]
18. Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation with survival in gastric cancer patients after radical gastrectomy.
Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Huang ZN; Lin JL; Zheng CH; Huang CM; Li P
Eur J Surg Oncol; 2019 Dec; 45(12):2465-2472. PubMed ID: 31350072
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
[TBL] [Abstract][Full Text] [Related]
20. The impact of the age-adjusted Charlson comorbidity index as a prognostic factor for endoscopic papillectomy in ampullary tumors.
Takada Y; Kawashima H; Ohno E; Ishikawa T; Mizutani Y; Iida T; Yamamura T; Kakushima N; Furukawa K; Nakamura M; Honda T; Ishigami M; Ito A; Hirooka Y
J Gastroenterol; 2022 Mar; 57(3):199-207. PubMed ID: 35098349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
